Targeting sphingosine kinase 2 to enhance CAR T-cell therapy efficacy in multiple myeloma
Research Grant
Administered By
Medicine, Hematologic Malignancies and Cellular Therapy
Awarded By
Cancer Research Institute
Start Date
September 1, 2025
End Date
August 31, 2027
Administered By
Medicine, Hematologic Malignancies and Cellular Therapy
Awarded By
Cancer Research Institute
Start Date
September 1, 2025
End Date
August 31, 2027